Cizumab 400mg is a high-quality injection formulation of Bevacizumab, a targeted therapy essential in oncology. This medication is pivotal in the treatment of various cancers by inhibiting the formation of new blood vessels (angiogenesis), effectively starving tumors of their blood supply. Cizumab is typically administered intravenously, often in combination with other chemotherapies, allowing for a synergistic effect against cancer. Patients receiving this infusion therapy can expect meticulous care in the delivery process, ensuring maximum efficacy and minimal discomfort. The Parshva Agency provides tailored private labeling solutions, adhering strictly to regulatory standards. Our state-of-the-art manufacturing processes guarantee product quality, efficacy, and safety. Store Cizumab at controlled temperatures between 2 - 8°C to preserve its integrity, and always consult a healthcare professional for proper usage and to understand potential side effects.

Key Features

Features Description
Generic Name Bevacizumab
Dosage Forms Cizumab 100mg Injection / Cizumab 400mg Injection
Storage Conditions Store at 2 - 8°C, do not freeze
Mechanism of Action Inhibits blood vessel growth in tumors
Administration Method Intravenous
Combination Therapy Often used with other cancer treatments
Regulatory Support Full compliance with industry standards
GMP Certification Manufactured in WHO-GMP certified facilities
Attributes Description
Product Name Cizumab
Active Ingredient Bevacizumab
Dosage 400mg
Formulation Injection
Quantity Single-use vial
Intended Use Cancer treatment

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.

Be the first to write a review

  • Incorporation Type

  • GST

  • GST Registration Date

  • Number of Employees

  • Import Export Code (IEC)

  • Year of Establishment

  • Nature of Business

  • GlobalLinker Member Since

Brand: PARSHVA AGENCY

Country Of Origin: India

Generic Name: Bevacizumab
Dosage:?Cizumab 100mg Injection?/ Cizumab 400mg Injection
Storage:?Store in a temperature (2 - 8?C). Do not freeze.
Bevacizumab Infusion is a medication commonly used in cancer treatment.
It works by inhibiting the growth of blood vessels within tumors, effectively limiting their blood supply. This infusion therapy is employed in the treatment of various cancer types and is typically administered intravenously.
Bevacizumab is often used in combination with other cancer therapies.
It is essential to consult with a healthcare provider or oncologist for guidance on its use and to understand potential side effects.

  • Customer-Centric Solutions: Parshva Agency focuses on delivering tailored private labeling services on a Peer-to-Peer (P2P) basis to meet the unique needs of each client.
  • Regulatory Support: The agency is backed by experienced regulatory experts who ensure full compliance with all industry standards, providing peace of mind to clients.
  • State-of-the-Art Manufacturing: Partnered with advanced manufacturing facilities that meet WHO-GMP certifications, Parshva Agency emphasizes the importance of modern production techniques.
  • Quality and Efficacy: With WHO-GMP certification, the agency guarantees that its products maintain the highest standards of quality and efficacy.
  • Reliability: Parshva Agency is committed to providing safe, reliable, and compliant products that meet stringent regulatory guidelines, fostering trust among clients and stakeholders.


Common Disease Medicines

Pharmaceutical Medicine

PARSHVA AGENCY

Cizumab 400mg

Bevacizumab

Cancer Treatment

Angiogenesis Inhibitor

Intravenous Infusion

Oncology Solutions

GMP Certified

Regulatory Support

Cizumab 400mg

Inclusive of all taxes

You Save: 0

Send Inquiry